On this page
Sodium Chloride
Overview
Active ingredients
Source: NDC DirectoryForms, strengths and routes
Source: NDC DirectoryPharmacologic classes are listed in the class section below.
Pharmacologic class
Source: NDC Directory| Class | Type | Browse |
|---|---|---|
| Increased Large Intestinal Motility [PE] | PE | All 83 members |
| Inhibition Large Intestine Fluid/Electrolyte Absorption [PE] | PE | All 83 members |
| Osmotic Activity [MoA] | MoA | All 105 members |
| Osmotic Laxative [EPC] | EPC | All 103 members |
Regulatory status
Source: Drugs@FDANDC Directory| Product | Trade name | Form | Strength | Ingredient | Status | TE | Flags |
|---|---|---|---|---|---|---|---|
| 017867-001 | SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER | SOLUTION | SODIUM CHLORIDE | Prescription | AT |
Therapeutic equivalence
Source: Orange BookWhat this rating means: Therapeutically equivalent — bioequivalence demonstrated (topical dermatological products)
Codes beginning with “A” indicate products the FDA considers therapeutically equivalent. Codes beginning with “B” indicate bioequivalence has not been established. See methodology.
Approval history
Source: Drugs@FDA| Type | No. | Action | Status | Date | Review |
|---|---|---|---|---|---|
| Supplement | 48 | Manufacturing (CMC) | Approved | August 29, 2001 | Standard |
| Supplement | 47 | Manufacturing (CMC) | Approved | January 28, 2000 | Standard |
| Supplement | 46 | Labeling | Approved | May 26, 1999 | — |
| Supplement | 45 | Manufacturing (CMC) | Approved | April 29, 1997 | Standard |
| Supplement | 43 | Manufacturing (CMC) | Approved | September 30, 1994 | Standard |
| Supplement | 44 | Manufacturing (CMC) | Approved | February 18, 1994 | Standard |
| Supplement | 42 | Manufacturing (CMC) | Approved | December 8, 1993 | Standard |
| Supplement | 40 | Labeling | Approved | May 8, 1991 | — |
| Supplement | 39 | Manufacturing (CMC) | Approved | March 26, 1991 | Standard |
| Supplement | 37 | Manufacturing (CMC) | Approved | February 15, 1991 | Standard |
| Supplement | 38 | Manufacturing (CMC) | Approved | May 24, 1990 | Standard |
| Supplement | 36 | Manufacturing (CMC) | Approved | July 26, 1989 | Standard |
| Supplement | 35 | Manufacturing (CMC) | Approved | January 12, 1989 | Standard |
| Supplement | 33 | Manufacturing (CMC) | Approved | July 25, 1987 | Standard |
| Supplement | 32 | Manufacturing (CMC) | Approved | May 28, 1987 | Standard |
| Supplement | 31 | Manufacturing (CMC) | Approved | February 27, 1986 | Standard |
| Supplement | 22 | Manufacturing (CMC) | Approved | August 28, 1985 | Standard |
| Supplement | 21 | Manufacturing (CMC) | Approved | August 28, 1985 | Standard |
| Supplement | 28 | Manufacturing (CMC) | Approved | June 13, 1985 | Standard |
| Supplement | 30 | Manufacturing (CMC) | Approved | April 15, 1985 | Standard |
| Supplement | 29 | Labeling | Approved | April 10, 1985 | — |
| Supplement | 27 | Labeling | Approved | January 26, 1985 | — |
| Supplement | 19 | Manufacturing (CMC) | Approved | January 24, 1985 | Standard |
| Supplement | 6 | Manufacturing (CMC) | Approved | January 24, 1985 | Standard |
| Supplement | 20 | Manufacturing (CMC) | Approved | March 16, 1984 | Standard |
| Supplement | 26 | Manufacturing (CMC) | Approved | February 28, 1984 | Standard |
| Supplement | 15 | Labeling | Approved | December 22, 1982 | — |
| Supplement | 14 | Manufacturing (CMC) | Approved | December 22, 1982 | Standard |
| Supplement | 24 | Labeling | Approved | December 3, 1982 | — |
| Supplement | 23 | Manufacturing (CMC) | Approved | December 3, 1982 | Standard |
| Supplement | 11 | Manufacturing (CMC) | Approved | June 3, 1982 | Standard |
| Supplement | 9 | Manufacturing (CMC) | Approved | April 16, 1982 | Standard |
| Supplement | 17 | Labeling | Approved | February 17, 1982 | — |
| Supplement | 8 | Manufacturing (CMC) | Approved | December 21, 1981 | Standard |
| Supplement | 13 | Manufacturing (CMC) | Approved | November 20, 1981 | Standard |
| Supplement | 7 | Manufacturing (CMC) | Approved | November 13, 1981 | Standard |
| Supplement | 10 | Manufacturing (CMC) | Approved | November 9, 1981 | Standard |
| Supplement | 5 | Manufacturing (CMC) | Approved | June 29, 1981 | Standard |
| Supplement | 4 | Manufacturing (CMC) | Approved | May 29, 1981 | Standard |
| Supplement | 3 | Manufacturing (CMC) | Approved | January 21, 1981 | Standard |
| Supplement | 2 | Manufacturing (CMC) | Approved | August 6, 1980 | Standard |
| Supplement | 1 | Manufacturing (CMC) | Approved | July 31, 1980 | Standard |
| Original application | 1 | Type 5 - New Formulation or New Manufacturer | Approved | May 30, 1980 | Standard |
Prescribing information
Source: openFDA Drug LabelingReproduced verbatim from the Structured Product Labeling submitted to the FDA (effective 20251102). This is the manufacturer's labelling text, not a summary and not advice.
Indications and Usage
openFDA Drug LabelingINDICATIONS AND USAGE This sterile, nonpyrogenic electrolyte solution is indicated for all general irrigation, washing, rinsing and dilution purposes including blood cell washing (when used in conjunction with automated intraoperative blood salvaging equipment).
Dosage and Administration
openFDA Drug LabelingDOSAGE AND ADMINISTRATION The dose is dependent upon the capacity or surface area of the structure to be irrigated and the nature of the procedure. When used as a diluent or vehicle for other drugs, the manufacturer's recommendations should be followed. For use in cell washing, the manufacturer's recommendations for blood salvaging and red cell processing should be followed. Drug Interactions Additives may be incompatible. Consult with pharmacist, if available. When introducing additives, use aseptic technique, mix thoroughly and do not store. Parenteral drug products should be inspected visually for particulate matter and discoloration prior to administration, whenever solution container permits. See PRECAUTIONS .
Contraindications
openFDA Drug LabelingCONTRAINDICATIONS 0.9% Sodium Chloride Irrigation USP is not for injection by usual parenteral routes. An electrolyte solution should not be used for irrigation during electrosurgical procedures.
Warnings
openFDA Drug LabelingWARNINGS FOR IRRIGATION ONLY. NOT FOR INJECTION. Irrigating fluids have been demonstrated to enter the systemic circulation in relatively large volumes; thus, irrigation solutions must be regarded as systemic drugs. Absorption of large amounts can cause fluid and/or solute overload resulting in dilution of serum electrolyte concentrations, overhydration, congested states or pulmonary edema. The risk of dilutional states is inversely proportional to the electrolyte concentrations of the administered parenteral solutions. The risk of solute overload causing congested states with peripheral and pulmonary edema is directly proportional to the electrolyte concentration. Do not warm above 150°F (66°C). After opening container, its contents should be used promptly to minimize the possibility of bacterial growth or pyrogen formation. Discard unused portion of irrigating solution since it contains no preservatives.
Adverse Reactions
openFDA Drug LabelingADVERSE REACTIONS Possible adverse effects arising from the irrigation of body cavities, tissues, or indwelling catheters and tubes can be minimized when proper procedures are followed. Displaced catheters or drainage tubes can lead to irrigation or infiltration of unintended structures or cavities. Excessive volume or pressure during irrigation of closed cavities may cause undue distension or disruption of tissues. Accidental contamination from careless technique may transmit infection. If an adverse reaction does occur, discontinue administration of the irrigant, evaluate the patient, institute appropriate therapeutic countermeasures, and save the remainder of the fluid for examination if deemed necessary.
Drug Interactions
openFDA Drug LabelingDrug Interactions Some additives may be incompatible. Consult with pharmacist. When introducing additives, use aseptic technique. Mix thoroughly. Do not store.
Description
openFDA Drug LabelingDESCRIPTION These products are sterile, nonpyrogenic solutions of electrolytes in water for injection intended only for sterile irrigation, washing, rinsing and dilution purposes. Each 100 mL of 0.9% Sodium Chloride Irrigation, USP contains: Sodium chloride 900 mg; pH 5.6 (4.5 to 7.0). May contain sodium hydroxide and/or hydrochloric acid for pH adjustment. The solution is isotonic (308 mOsmol/liter, CALC.) and has the following electrolyte content (mEq/liter): Na + 154; Cl − 154. These irrigations contain no bacteriostat, antimicrobial agent or added buffer and are intended only for use as single-dose or short procedure irrigation. When smaller volumes are required the unused portion should be discarded. Each of these irrigations may be classified as a sterile irrigant, wash, rinse, diluent and pharmaceutical vehicle. Sodium Chloride, USP is chemically designated NaCl, a white crystalline powder freely soluble in water. Water for Injection, USP is chemically designated H 2 O. The flexible plastic container is fabricated from a specially formulated polyvinylchloride. Water can permeate from inside the container into the overwrap but not in amounts sufficient to affect the solution significantly. The semi-rigid container is fabricated from a specially formulated polyolefin. It is a copolymer of ethylene and propylene. The container requires no vapor barrier to maintain the proper drug concentration. Solutions in contact with the plastic container may leach out certain chemical components from the plastic in very small amounts; however, biological testing was supportive of the safety of the plastic container materials. Exposure to temperatures above 25°C/77°F during transport and storage will lead to minor losses in moisture content. Higher temperatures lead to greater losses. It is unlikely that these minor losses will lead to clinically significant changes within the expiration period.
Overdosage
openFDA Drug LabelingOVERDOSAGE In the event of overhydration or solute overload, reevaluate the patient’s condition, and institute appropriate corrective treatment. Intravascular volume overload may respond to hemodialysis. See WARNINGS , PRECAUTIONS , and ADVERSE REACTIONS .
How Supplied / Storage and Handling
openFDA Drug LabelingHOW SUPPLIED 0.9% Sodium Chloride Irrigation, USP: Container Size NDC Single-dose 500 mL semi-rigid irrigation container 0409-6138-03 Manufactured for ICU Medical, Inc., Lake Forest, Illinois, 60045, USA Single-dose 500 mL semi-rigid irrigation container 0990-6138-03 Single-dose 250 mL semi-rigid irrigation container 0409-6138-22 Single-dose 250 mL semi-rigid irrigation container 0990-6138-22 Single-dose 1000 mL semi-rigid irrigation container 0409-7138-09 Single-dose 1000 mL semi-rigid irrigation container 0990-7138-09 Single-dose 1500 mL semi-rigid irrigation container 0409-7138-36 Single-dose 1500 mL semi-rigid irrigation container 0990-7138-36 Single-dose 1000 mL flexible irrigation container 0409-7972-05 Manufactured by ICU Medical, Inc., Lake Forest, Illinois, 60045, USA Single-dose 1000 mL flexible irrigation container 0990-7972-05 Single-dose 2000 mL flexible irrigation container 0409-7972-07 Single-dose 2000 mL flexible irrigation container 0990-7972-07 ICU Medical is transitioning NDC codes from "0409" to "0990" labeler code. Both NDC codes are expected to be in the market for a period of time. Store at 20 to 25°C (68 to 77°F). [See USP Controlled Room Temperature.] Protect from freezing. Revised: July, 2018 EN-4660 ICU Medical, Inc., Lake Forest, Illinois, 60045, USA
Adverse event reports
Source: openFDA FAERSAttributed to this product's most-reported active ingredient: SODIUM CHLORIDE. Combination products with more than six active ingredients are not attributed, because a report count summed across a long ingredient list measures the list, not the medicine.
Recalls
Source: FDA Enforcement| Classification | Reported | Firm | Reason | Status |
|---|---|---|---|---|
| Class II | April 16, 2025 | B. Braun Medical Inc | Presence of Particulate Matter | Ongoing |
| Class II | March 31, 2021 | ICU Medical Inc | Presence of particulate matter.one confirmed customer report of particulate matter within two semi-rigid bottles identified prior to use | Terminated |
| Class II | November 27, 2019 | Baxter Healthcare Corporation | Lack of Assurance of Sterility: Product has the potential to leak. | Terminated |
| Class II | March 7, 2018 | B. Braun Medical Inc | Presence of Particulate Matter: Customer complaint of particulate matter which has been identified as polyethylene, which is consistent with the material used to manufacture the container cap was received. | Terminated |
| Class II | March 9, 2016 | Baxter Healthcare Corp. | PRESENCE OF PARTICULATE MATTER: Product complaint for the presence of particulate matter identified as an insect. | Terminated |
| Class II | May 7, 2014 | Baxter Healthcare Corp. | Presence of Particulate Matter: Nylon fibers found in a bottle of 0.9% sodium chloride for irrigation. | Terminated |
Packaging and NDCs
Source: NDC Directory| Package NDC | Product NDC | Labeler | Description | Marketing start |
|---|---|---|---|---|
| 0264-2201-00 | 0264-2201 | B. Braun Medical Inc. | 16 CONTAINER in 1 CASE (0264-2201-00) / 1000 mL in 1 CONTAINER | September 14, 2009 |
| 0264-2201-10 | 0264-2201 | B. Braun Medical Inc. | 16 CONTAINER in 1 CASE (0264-2201-10) / 500 mL in 1 CONTAINER | September 14, 2009 |
| 0338-0047-44 | 0338-0047 | Baxter Healthcare Company | 14 BAG in 1 CARTON (0338-0047-44) / 1000 mL in 1 BAG | May 30, 1980 |
| 0338-0047-46 | 0338-0047 | Baxter Healthcare Company | 6 BAG in 1 CARTON (0338-0047-46) / 2000 mL in 1 BAG | May 30, 1980 |
| 0338-0047-47 | 0338-0047 | Baxter Healthcare Company | 4 BAG in 1 CARTON (0338-0047-47) / 3000 mL in 1 BAG | May 30, 1980 |
| 0338-0110-04 | 0338-0110 | Baxter Healthcare Company | 4 BAG in 1 CARTON (0338-0110-04) / 3000 mL in 1 BAG (0338-0110-01) | November 13, 2024 |
| 0338-9834-04 | 0338-9834 | Baxter Healthcare Company | 4 BAG in 1 CARTON (0338-9834-04) / 3000 mL in 1 BAG (0338-9834-01) | December 3, 2024 |
| 0338-0047-27 | 0338-0047 | Baxter Healthcare Corporation | 4 BAG in 1 CARTON (0338-0047-27) / 3000 mL in 1 BAG | May 30, 1980 |
| 0338-0047-29 | 0338-0047 | Baxter Healthcare Corporation | 2 BAG in 1 CARTON (0338-0047-29) / 5000 mL in 1 BAG | May 30, 1980 |
| 0338-0048-02 | 0338-0048 | Baxter Healthcare Corporation | 24 BOTTLE, PLASTIC in 1 CARTON (0338-0048-02) / 250 mL in 1 BOTTLE, PLASTIC | December 31, 1974 |
| 0338-0048-03 | 0338-0048 | Baxter Healthcare Corporation | 18 BOTTLE, PLASTIC in 1 CARTON (0338-0048-03) / 500 mL in 1 BOTTLE, PLASTIC | December 31, 1974 |
| 0338-0048-04 | 0338-0048 | Baxter Healthcare Corporation | 12 BOTTLE, PLASTIC in 1 CARTON (0338-0048-04) / 1000 mL in 1 BOTTLE, PLASTIC | December 31, 1974 |
| 0338-0051-44 | 0338-0051 | Baxter Healthcare Corporation | 1000 mL in 1 BAG (0338-0051-44) | May 17, 1985 |
| 0990-7972-05 | 0990-7972 | ICU Medical Inc. | 12 BAG in 1 CASE (0990-7972-05) / 1000 mL in 1 BAG | January 1, 2020 |
| 0990-7972-07 | 0990-7972 | ICU Medical Inc. | 6 BAG in 1 CASE (0990-7972-07) / 2000 mL in 1 BAG | August 1, 2019 |
| 0990-7972-08 | 0990-7972 | ICU Medical Inc. | 4 POUCH in 1 CASE (0990-7972-08) / 1 BAG in 1 POUCH / 3000 mL in 1 BAG | July 1, 2019 |
| 0264-2201 | 0264-2201 | B. Braun Medical Inc. | — | September 14, 2009 |
| 0338-0047 | 0338-0047 | Baxter Healthcare Company | — | May 30, 1980 |
| 0338-0110 | 0338-0110 | Baxter Healthcare Company | — | November 13, 2024 |
| 0338-9834 | 0338-9834 | Baxter Healthcare Company | — | December 3, 2024 |
| 0338-0048 | 0338-0048 | Baxter Healthcare Corporation | — | December 31, 1974 |
| 0338-0051 | 0338-0051 | Baxter Healthcare Corporation | — | May 17, 1985 |
| 0990-7972 | 0990-7972 | ICU Medical Inc. | — | July 1, 2019 |
Sources for this page
| Dataset | Agency | Used for |
|---|---|---|
| NDC Directory | FDA | Identity, ingredients, strengths, forms, routes, labelers, packages |
| Drugs@FDA | FDA | Application, sponsor, submissions, review documents, marketing status |
| Orange Book | FDA | Therapeutic equivalence codes, reference drug flags, patents, exclusivity |
| Drug Labeling | FDA / NLM | Prescribing information reproduced above |
| FAERS | FDA | Adverse event report counts |
| Enforcement | FDA | Recall records |
Generated September 25, 2026 · 13 sections on this page.